ALAlphabet Inc.
Institutional investor · Portfolio as of Q4 2023
Top Holdings44 positions
DEXCOM INC | 3.7M | $456.9M | 21.2% | $115.76 | +7.20% | 18 qtrssince 2019-Q3 | Increased 99 |
CROWDSTRIKE HLDGS INC | 1.3M | $327.7M | 15.2% | $30.67 | +108.14% | 5 qtrssince 2022-Q4 | Unchanged 0 |
UIPATH INC CLASS A | 7M | $174.7M | 8.1% | $67.93 | -63.43% | 11 qtrssince 2021-Q2 | Decreased 0 |
VERVE THERAPEUTICS INC | 12.3M | $172.1M | 8.0% | — | — | 11 qtrssince 2021-Q2 | Increased 70 |
GITLAB INCCL A | 2.6M | $166.7M | 7.7% | $46.00 | +36.86% | 7 qtrssince 2022-Q2 | Unchanged 0 |
REVOLUTION MEDICINES INC | 5.3M | $152M | 7.0% | $28.68 | 0.00% | 1 qtr | New 95 |
ARM HOLDINGS PLC | 2M | $147.3M | 6.8% | $53.52 | +40.41% | 2 qtrssince 2023-Q3 | Unchanged 0 |
SNOWFLAKE INC | 535,604 | $106.6M | 4.9% | $229.13 | -13.15% | 8 qtrssince 2022-Q1 | Unchanged 0 |
PRIME MEDICINE INC | 11.9M | $105.1M | 4.9% | $18.58 | -52.31% | 5 qtrssince 2022-Q4 | Unchanged 0 |
FRESHWORKS INCCL A | 4M | $94.8M | 4.4% | $26.26 | -10.55% | 9 qtrssince 2021-Q4 | Unchanged 0 |
PLANET LABS PBC | 31.9M | $78.9M | 3.7% | $6.15 | -59.84% | 9 qtrssince 2021-Q4 | Unchanged 0 |
INVIVYD INC | 5.7M | $22.4M | 1.0% | $42.24 | -90.67% | 10 qtrssince 2021-Q3 | Unchanged 0 |
RELAY THERAPEUTICS INC | 1.6M | $17.3M | 0.8% | $41.71 | -73.60% | 14 qtrssince 2020-Q3 | Unchanged 0 |
OSCAR HEALTH INC CLASS A | 1.6M | $14.9M | 0.7% | $26.88 | -65.96% | 12 qtrssince 2021-Q1 | Decreased 0 |
RAPT THERAPEUTICS INC | 540,270 | $13.4M | 0.6% | — | — | 17 qtrssince 2019-Q4 | Unchanged 0 |
SANA BIOTECHNOLOGY INC | 2.8M | $11.5M | 0.5% | $33.47 | -87.81% | 12 qtrssince 2021-Q1 | Unchanged 0 |
LYELL IMMUNOPHARMA INC | 5.9M | $11.4M | 0.5% | $324.80 | -88.05% | 11 qtrssince 2021-Q2 | Unchanged 0 |
BEAM THERAPEUTICS INC | 321,604 | $8.8M | 0.4% | $18.00 | +51.22% | 16 qtrssince 2020-Q1 | Unchanged 0 |
Desktop Metal Inc | 11M | $8.3M | 0.4% | — | — | 13 qtrssince 2020-Q4 | Unchanged 0 |
MONTE ROSA THERAPEUTICS INC | 1.5M | $8.3M | 0.4% | $22.70 | -75.11% | 11 qtrssince 2021-Q2 | Unchanged 0 |
Alphabet Inc. manages $2.2B across 44 positions as of Q4 2023. Top holdings: DXCM (21.2%), CRWD (15.2%), PATH (8.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added RVMD and SNCE; exited EQRX, SNCE and EVLO; increased 3, led by DXCM (+3M shares); trimmed 2, led by PATH (−7M shares). Top move: DXCM (INCREASED, conviction 99). Portfolio: $2.2B across 44 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR